Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin antiplatelet effect after cardiac valve surgery: impact of metamizole versus paracetamol
2018-000017-20Phase 4Completed
- Sponsor
- Universitäts-Herzzentrum Freiburg-Bad Krozingen
- Start
- May 2018
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Metamizole sodium, acetaminophen and aspirin in pain and Cardiac valve disease (VHD) (2 arms), sponsored by Universitäts-Herzzentrum Freiburg-Bad Krozingen. Started May 2018; status: completed.
02
Drugs
Metamizole sodiumacetaminophenaspirin
03
Conditions
painCardiac valve disease (VHD)
Beyond the preview
Go deeper on 2018-000017-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000017-20.